YM Biosciences Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Toronto Canada (1994)
Status: Acquired by Gilead Sciences (2013)

Organization Overview

First Clinical Trial
2001
NCT00708318
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CIMYM BioSciences | YM BioSciences | YM Biosciences Inc.